• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

COVID-19

Oramed forms joint venture to develop oral COVID-19 vaccines with POD delivery tech

March 19, 2021 By Sean Whooley

Oramed

Oramed Pharmaceuticals (NSDQ:ORMP) announced today that it is forming a joint venture to develop novel oral COVID-19 vaccines. New York-based Oramed entered into definitive agreements to form Oravax Medical, which is based on Oramed’s proprietary POD (protein oral delivery) technology and Premas Biotech’s novel vaccine technology, according to a news release. Oravax’s COVID-19 vaccine candidate […]

Filed Under: Business/Financial News, Discovery, Drug-Device Combinations, Featured, Pharmaceuticals, Research & Development Tagged With: coronavirus, COVID-19, COVID-19 vaccine, oramedpharmaceuticals

NeuroRX, TFF Pharmaceuticals enter feasibility agreement for Zyesami dry powder for COVID-19

March 10, 2021 By Sean Whooley

NeuroRx TFF Pharmaceuticals

NeuroRx and TFF Pharmaceuticals (NSDQ:TFFP) announced a feasibility agreement for the former’s Zyesami therapeutic. Zyesami (aviptadil, synthetic VIP) materials are set to be delivered to TFF to perform feasibility formulation work and testing in an effort to identify an optimal, long-term, stable formulation of Zyesami into a dry powder form for aerosol delivery directly to […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Pharmaceuticals, Research & Development Tagged With: coronavirus, COVID-19, NeuroRx, TFF Pharmaceuticals

Baxter to make Moderna COVID-19 vaccine in US

March 9, 2021 By Chris Newmarker

Baxter Moderna

Baxter announced that its Baxter BioPharma Solutions business will make Moderna‘s COVID-19 vaccine at its fill/finish sterile manufacturing facilities in Bloomington, Ind. The plan — announced yesterday — is for Baxter to make 60–90 million doses of the Moderna vaccine in 2021. “We have seen a remarkable demonstration of scientific and health care expertise in […]

Filed Under: Contract Services, Featured Tagged With: Baxter, coronavirus, COVID-19, Moderna

Intranasal COVID-19 vaccines could be on the horizon

March 8, 2021 By Brian Buntz

Image courtesy of AltImmune

All of the COVID-19 vaccines authorized to date are delivered via intramuscular injection. But the intranasal vaccines that are now in development could lead to a more diverse vaccine landscape.  The company Altimmune (Gaithersburg, Md.) recently launched a Phase 1 clinical trial to test its single-dose adCOVID intranasal vaccine in 180 adult volunteers. Bharat Biotech […]

Filed Under: Clinical Trials, Otolaryngology Ear, Nose & Throat, Pediatrics, Pharmaceuticals, Research & Development, Respiratory Tagged With: COVID-19, intranasal, Intranasal COVID-19 vaccines

Pneumagen touts non-human results for intranasal drug treatment for COVID-19

March 8, 2021 By Sean Whooley

Pneumagen

Pneumagen announced today that study results show the effectiveness of its Neumifil intranasal drug in treating COVID-19. St. Andrews, Scotland-based Pneumagen’s Neumafil, a viral intranasal drug for protection against respiratory tract infections (RTIs), was used on a hamster model of COVID-19 infection and displayed effectiveness as it significantly reduced clinical signs and weight loss in […]

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Otolaryngology Ear, Nose & Throat, Pharmaceuticals, Research & Development, Respiratory Tagged With: coronavirus, COVID-19, Pneumagen

Why COVID-19 could drive a surge in diabetes 

February 1, 2021 By Brian Buntz

diabetes devices

Diabetes was already an epidemic before the novel coronavirus struck. But some researchers now suspect that COVID-19 can trigger the condition. Approximately 14% of patients with severe COVID-19 develop the disease, according to a meta-analysis recently published in the journal Diabetes, Obesity and Metabolism. To arrive at that thesis, the researchers analyzed eight studies. Half of […]

Filed Under: Diabetes, Featured Tagged With: COVID-19, Diabetes, novel coronavirus

Biden’s COVID-19 response will make manufacturers busy

January 21, 2021 By Nancy Crotti

Manufacturers of vaccine supplies and personal protective equipment can expect more work as the new Biden administration rolls out its plans to combat the COVID-19 pandemic. In one of his first official acts as president, Joe Biden announced a plan to “fully use” the Defense Production Act to ramp up production of testing supplies, masks, […]

Filed Under: Business/Financial News, Distribution, Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: 3M, AdvaMed, Becton Dickinson, coronavirus, COVID-19, Defense Production Act, medical device manufacturers association (MDMA), vaccines

How Dexcom CEO Kevin Sayer is leading the company forward

December 21, 2020 By Sean Whooley

Dexcom updated logo

Like most companies in 2020, Dexcom (NSDQ:DXCM) faced a number of challenges brought on by COVID-19, public unrest and more. Dexcom chairman, president & CEO Kevin Sayer had to prioritize the health of his employees over all else, while also keeping patients safe and somehow managing to keep the diabetes giant rolling as a business. “Anybody who […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured Tagged With: coronavirus, COVID-19, Dexcom

BREAKING: BD orders for COVID-19 vaccine injection devices surpass 1 billion

December 16, 2020 By Chris Newmarker

BD logo

Becton Dickinson (NYSE:BDX) announced today that orders have surpassed 1 billion for syringes and needles needed to deliver COVID-19 vaccines. The Franklin Lakes, N.J.–based medtech giant now has commitments from governments in countries including the United States, Australia, Belgium, Canada, Germany, Netherlands, Saudi Arabia, Spain and the United Kingdom. BD has already delivered more than 300 […]

Filed Under: Drug-Device Combinations, Featured Tagged With: BD, coronavirus, COVID-19, syringes

BD is playing a crucial role delivering COVID-19 vaccines: Here’s how

December 15, 2020 By Chris Newmarker

BD needles syringes

Hundreds of millions of vaccine doses will require hundreds of millions of syringes from companies such as BD. As much-hoped-for COVID-19 vaccines roll out to the public, Becton Dickinson (NYSE:BDX) faces an arguably impressive challenge: The Franklin Lakes, N.J.–based medtech giant already has commitments to provide more than 800 million needles and syringes to deliver future COVID-19 […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured Tagged With: BD, coronavirus, COVID-19, syringes

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Go to page 6
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Souring
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS